Name: MHUAF Income Statement - Meihua International Medical Technologies Co. Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

MHUAF - Meihua International Medical Technologies Co. Ltd.

USD | OTC Markets | Healthcare

MHUAF Income Statement - Meihua International Medical Technologies Co. Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Revenues
Revenues	61.8	96.9	97.1	103.3	104.0	89.1	79.6
Cost of Revenue	42.6	63.6	63.9	65.2	64.2	51.9	47.4
Gross Profit	19.2	33.3	33.2	38.1	39.8	37.2	32.2
Operating Expenses
Research & Development	2.4	3.5	2.8	3.0	2.7	2.5	3.2
Selling General & Administrative	-	-	-	-	-	-
Operating Income
Operating Income	8.3	14.3	14.7	10.8	26.3	23.5	19.4
Non-Operating
Interest Income	1.3	1.0	0.9	0.1	0.0	-	-
Interest Expense	0.2	1.5	0.3	0.2	0.2	0.1	0.1
Tax & Net
Income Tax Expense	2.6	2.8	3.5	4.7	5.3	4.7	3.8
Net Income From Continuing Ops	6.8	10.8	11.6	6.2	20.9	19.0
Per Share
EPS Basic	18.04	39.62	48.56	0.27	1.05	0.95	0.83
EPS Diluted	18.04	39.62	48.56	0.27	1.05	0.95	-
Supplementary Data
EBITDA	8.8	14.9	15.1	11.3	26.9	24.0	19.9
EBIT	8.3	14.3	14.7	10.8	26.3	23.5	19.4

Source: SEC EDGAR company filings. Figures as reported (US GAAP)